News Related to Squamous Cell Carcinoma

Related coverage linked through entity extraction aliases.

PD-1 and PD-L1 Inhibitors Market Expands with 200+ Drugs in Development Across 180+ Companies

Feb 19, 2026

A comprehensive market report reveals over 180 companies are developing more than 200 PD-1 and PD-L1 inhibitor drugs, with recent fast-track designations and successful Phase III trial results driving expansion in cancer immunotherapy.

T-VEC Oncolytic Virus Shows Promise in Breast Cancer and Nonmelanoma Skin Cancer Trials

Feb 23, 2026

Two clinical trials demonstrate efficacy of talimogene laherparepvec (T-VEC) oncolytic virus therapy in HER2-negative breast cancer and nonmelanoma skin cancers, with favorable safety profiles and durable responses in subset of patients.